Antiviral immunity, obesity and pulmonary fibrosis will be discussed by three Vanderbilt University researchers during a Cutting-Edge Discovery Lecture on Nov. 21. The lecture will begin at 4 p.m. in 208 Light Hall.
Human respiratory syncytial virus (RSV) is a primary cause of lower respiratory tract infections among young children worldwide, and leads to 60,000 deaths globally each year. A vaccine does not yet exist, although several candidates are in development.
Vanderbilt University Medical Center will be the first in the state to offer a minimally invasive, non-surgical alternative for patients with emphysema.
The bacterial toxin lipopolysaccharide (LPS) is one of the most potent virulence factors of Gram-negative bacteria that cause sepsis. Exposure to even tiny amounts can trigger a systemic — and potentially lethal — inflammatory response known as endotoxin shock.
Acute kidney injury (AKI) — a sudden loss in kidney function that often occurs in hospitalized patients — puts survivors at increased risk for future chronic kidney and cardiovascular disease.
Diabetes is the leading cause of end-stage renal disease, one of the nation’s most debilitating and expensive medical conditions. In 2016 Medicare spent $35 billion caring for more than 725,000 Americans whose kidneys had failed.
A program in the Medical Intensive Care Unit at Vanderbilt University Adult Hospital has successfully removed penicillin allergy labels from more than 45 inpatients at high risk to receive antibiotics, but whose penicillin allergies were low risk.
A new randomized trial examines the effect of automated clinical decision support on team evaluation of pediatric inpatients at high risk for acute kidney injury (AKI).
A study of 280,000 U.S. veterans including 56,000 African Americans has identified in greater detail than ever before the “genetic architecture” of kidney function and chronic kidney disease (CKD), according to researchers at Vanderbilt University Medical Center and their colleagues.